House Bill 3248
118th Congress(2023-2024)
Diagnostic Lab Testing Transparency Act
Introduced
Introduced in House on May 11, 2023
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3248
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Diagnostic Lab Testing Transparency Act
This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.
Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.
May 11, 2023
Sort by most recent
05/12/2023
Referred to the Subcommittee on Health.
05/11/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/11/2023
Introduced in House
Public Record
Record Updated
Jan 12, 2024 7:30:20 PM